Public Citizen | Publications - Statement Before the Institute of Medicine Committee on Developing Cancer Biomarkers: A Case Study Involving ACF/orlistat (HRG Publication #1773)

Worst Pills, Best Pills

Health Letter

Health Links

Activist Courses

Take Action!

Drug Safety

Healthcare Delivery

Medical Devices

Food Safety

Occupational Health

advanced search

JOIN US! |Take Action | Publications | About Health Research | Contact Us

Statement Before the Institute of Medicine Committee on Developing Cancer Biomarkers: A Case Study Involving ACF/orlistat (HRG Publication #1773)

Statement by Sidney M. Wolfe MD
Public Citizen’s Health Research Group

Biomarkers for Screening, Diagnosis and Treatment of Cancer:
Why Not for Harm Prevention as Well?
A Case Study Involving ACF/orlistat

Institute of Medicine
Committee on Developing Cancer Biomarkers

June 15, 2006

Click HERE to view the presentation slides in pdf format

more resources

Press Releases
Statements
Testimony

Back to Publications Index>>

»	publications

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.

| | | | |